Health services research using a mixed-methods design: quality assurance in breast cancer aftercare - OnkoMobil

Medizinische Universität Graz0 个研究点目标入组 1,400 人开始时间: 2026年8月1日最近更新: 2026年8月3日

适应症

试验速览

暂无简介。

•Female Patients:
•Primary disease or recurrence of a diagnosed hormone receptor-positive, HER2-negative breast cancer (C50)
•Curative treatment plan with no indication for (neo-)adjuvant chemotherapy
•AJCC tumour stage I
•Completion of treatment: surgery, radiotherapy
•Written consent from patients to participate in OnkoMobil Steiermark (relates to the research component)
•Sufficient ability of the patient and/or their personal support network to communicate digitally
•Sufficient cognitive abilities (including adherence)
•Willingness to participate in the OnkoMobil Steiermark project
•Resident in Styria, registered with the Austrian social security system
•Long-term follow-up: Willingness to participate in the study over an extended period (for at least 5 years following surgery)
•Technical requirements: Access to a smartphone, tablet or PC with internet access; basic digital literacy or willingness to receive training
•Language: Sufficient command of spoken and written German
•Primary care providers:

•Female patients:
•Metastatic breast cancer or untreated breast cancer
•Severe mental or cognitive impairments (e.g. dementia, severe depression, psychosis)
•Active other tumour diseases or ongoing follow-up care due to other tumour diseases
•Life expectancy of less than 12 months
•No digital access (lack of infrastructure or unwillingness to use digital formats)
•Participation in an interventional trial with potential interference
•Planned change of residence from Styria within the next 12 months
•Acute, severe comorbid condition that makes participation in a long-term study unreasonable
•Primary care providers:
•No exclusion criteria

发起方